Although a wide variety of drugs are available for treatment of epilep
sy, many patients with epilepsy still experience uncontrolled seizures
. In addition, there is a need for new drugs that can halt epileptogen
esis after brain injury. Mechanisms that underlie seizure processes co
nstitute potential target areas for the development of new antiepilept
ic drugs (AEDs). An understanding of the underlying mechanisms of inte
rictal spike discharge and seizure spread is critical for the developm
ent of AEDs for treatment of partial seizures. Suppression of specific
forms of voltage-dependent calcium currents and inhibition of GABA(B)
receptor-mediated inhibition are two key target areas for new AEDs to
treat primary generalized seizures. As researchers gain more understa
nding of the cellular, molecular, and genetic mechanisms underlying se
izure propagation, we should be better able to develop therapeutic age
nts designed to suppress seizure-provoking mechanisms and to enhance t
he brain's natural protective mechanisms.